European Regulator Calls for Amgen’s Tavneos to Have Authorization Revoked
European regulators are recommending the revocation of marketing authorization for Amgen's rare-disease drug Tavneos following new data.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The Committee for Medicinal Products for Human Use (CHMP) has reversed its endorsement of Tavneos, a drug used for an autoimmune disease. European regulators are now recommending that the marketing authorization for the Amgen-developed treatment be revoked.
Coverage from Reuters, the Wall Street Journal, Endpoints News, and Fierce Pharma emphasizes the shift in the regulator's position. Medscape reports that the decision to revoke the drug's status was driven by new data.
Attention now turns to an upcoming FDA hearing regarding the drug, as noted in coverage from Fierce Pharma.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 5h ago.
Quick answers
What drug is facing authorization revocation?
The drug is Tavneos, developed by Amgen.
Why is the authorization being revoked?
According to Medscape, the decision was prompted by new data.
Which regulatory body issued the recommendation?
The recommendation was made by the CHMP (Committee for Medicinal Products for Human Use).
Coverage (6)
- Inside FDA’s Effort to Pull an Amgen Drug Over Alleged Data Manipulation Bloomberg · 11h ago
- New Data Lead to Decision to Revoke Autoimmune Disease Drug Medscape · 11h ago
- Europe's CHMP reverses endorsement of Tavneos as Amgen FDA hearing looms Fierce Pharma · 11h ago
- EU regulators recommend revoking the marketing authorization for Amgen’s Tavneos Endpoints News · 11h ago
- EU regulator backs revoking Amgen's right to sell rare-disease drug Reuters · 11h ago
- European Regulator Calls for Amgen’s Tavneos to Have Authorization Revoked WSJ · 11h ago broke it first
People, places & organizations
Topics
Related trends
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026
Eli Lilly shares surge following the CHMP's recommendation for the approval of Jaypirca in the European Union.
EU restricts protections for Ukrainian men at Kyiv's request
The European Union is proposing to exclude military-age Ukrainian men from its temporary protection scheme following a request from Kyiv.
Paramount-Warner Merger Reportedly Set To Clear EU Antitrust Hurdles
Paramount is moving closer to finalizing its $110-111 billion merger with Warner Bros. Discovery as EU antitrust hurdles likely clear.
US and Qatar claim EU methane rules will trigger gas supply crunch
The US and Qatar warn that new EU methane regulations could jeopardize energy security and trigger a gas supply shortage.
Murdered Activist Was Probing President's Family Business
International calls for transparency rise following the murder of Polish activist Monika Silva Koniuszek in Ecuador.